Engineered probiotics remodel tumor immune micro-environment for enhanced breast cancer metastasis inhibition and checkpoint inhibitor treatment | Synapse
March 3, 2026
Engineered probiotics remodel tumor immune micro-environment for enhanced breast cancer metastasis inhibition and checkpoint inhibitor treatment
Key Points
Probiotics enhance the tumor micro-environment, leading to improved inhibition of breast cancer metastasis.
Engineered probiotics significantly reduced metastasis by 60%, indicating a strong immune response.
This analysis examines the effects of probiotics on tumor immune modulation and checkpoint inhibitor treatment.
The findings support potential new therapies that leverage probiotics for cancer treatment.